Role of the HefC efflux pump in helicobacter pylori cholesterol-dependent resistance to ceragenins and bile salts

Infection and Immunity

Volumn 79, Issue 1, 2011, Pages 88-97

  Trainor, Elizabeth A ^a   Horton, Katherine E ^a   Savage, Paul B ^b   Testerman, Traci L ^a   McGee, David J ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b Brigham Young University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; BILE SALT; CERAGENIN 11; CERAGENIN 13; CERAGENIN 54; CERAGENIN 90; CHOLESTEROL; CHOLESTERYL GLYCOSYLTRANSFERASE; GLYCOSYLTRANSFERASE; POLYPEPTIDE ANTIBIOTIC AGENT; PROTEI HEFF; PROTEIN HEFC; PROTEIN HEFI; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GROWTH; BACTERIAL MUTATION; BACTERIAL STRAIN; BACTERIUM CULTURE; CONTROLLED STUDY; DILUTION; DISEASE PREDISPOSITION; GLYCOSYLATION; HELICOBACTER PYLORI; NONHUMAN; PRIORITY JOURNAL;

BACTERIAL PROTEINS; BILE ACIDS AND SALTS; CARRIER PROTEINS; CHOLESTEROL; DRUG RESISTANCE, BACTERIAL; GENE EXPRESSION REGULATION, BACTERIAL; HELICOBACTER PYLORI; MOLECULAR STRUCTURE; MUTATION; STEROIDS;

EID: 78650925895     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00974-09     Document Type: Article

References (46)

1. Ansorg, R., K. D. Muller, G. von Recklinghausen, and H. P. Nalik. 1992. Cholesterol binding of Helicobacter pylori. Zentralbl. Bakteriol. 276:323-329.
2. Baltrus, D. A., M. R. Amieva, A. Covacci, T. M. Lowe, D. S. Merrell, K. M. Ottemann, M. Stein, N. R. Salama, and K. Guillemin. 2009. The complete genome sequence of Helicobacter pylori strain G27. J. Bacteriol. 191:447-448.
3. Belzer, C., J. Stoof, S. Breijer, J. G. Kusters, E. J. Kuipers, and A. H. van Vliet. 2009. The Helicobacter hepaticus hefA gene is involved in resistance to amoxicillin. Helicobacter 14:72-79.
4. Bina, J. E., R. A. Alm, M. Uria-Nickelsen, S. R. Thomas, T. J. Trust, and R. E. Hancock. 2000. Helicobacter pylori uptake and efflux: basis for intrinsic susceptibility to antibiotics in vitro. Antimicrob. Agents Chemother. 44:248-254.
5. Bina, X. R., J. A. Philippart, and J. E. Bina. 2009. Effect of the efflux inhibitors 1-(1-naphthylmethyl)-piperazine and phenyl-arginine-beta-naph- thylamide on antimicrobial susceptibility and virulence factor production in Vibrio cholerae. J. Antimicrob. Chemother. 63:103-108.
6. Bina, X. R., D. Provenzano, N. Nguyen, and J. E. Bina. 2008. Vibrio cholerae RND family efflux systems are required for antimicrobial resistance, optimal virulence factor production, and colonization of the infant mouse small intestine. Infect. Immun. 76:3595-3605.
7. Chalker, A. F., H. W. Minehart, N. J. Hughes, K. K. Koretke, M. A. Lonetto, K. K. Brinkman, P. V. Warren, A. Lupas, M. J. Stanhope, J. R. Brown, and P. S. Hoffman. 2001. Systematic identification of selective essential genes in Helicobacter pylori by genome prioritization and allelic replacement mu-tagenesis. J. Bacteriol. 183:1259-1268.
8. Chin, J. N., R. N. Jones, H. S. Sader, P. B. Savage, and M. J. Rybak. 2008. Potential synergy activity of the novel ceragenin, CSA-13, against clinical isolates of Pseudomonas aeruginosa, including multidrug-resistant P. aerugi-nosa. J. Antimicrob. Chemother. 61:365-370.
9. Chin, J. N., M. J. Rybak, C. M. Cheung, and P. B. Savage. 2007. Antimicrobial activities of ceragenins against clinical isolates of resistant Staphylo-coccus aureus. Antimicrob. Agents Chemother. 51:1268-1273.
10. Ding, B., Q. Guan, J. P. Walsh, J. S. Boswell, T. W. Winter, E. S. Winter, S. S. Boyd, C. Li, and P. B. Savage. 2002. Correlation of the antibacterial activities of cationic peptide antibiotics and cationic steroid antibiotics. J. Med. Chem. 45:663-669.
11. Drew, D., M. M. Klepsch, S. Newstead, R. Flaig, J. W. De Gier, S. Iwata, and K. Beis. 2008. The structure of the efflux pump AcrB in complex with bile acid. Mol. Membr. Biol. 25:677-682.
12. Epand, R. M., R. F. Epand, and P. B. Savage. 2008. Ceragenins (cationic steroid compounds), a novel class of antimicrobial agents. Drug News Per-spect. 21:307-311.
13. Goodwin, A., D. Kersulyte, G. Sisson, S. J. Veldhuyzen van Zanten, D. E. Berg, and P. S. Hoffman. 1998. Metronidazole resistance in Helicobacter pylori is due to null mutations in a gene (rdxA) that encodes an oxygen-insensitive NADPH nitroreductase. Mol. Microbiol. 28:383-393.
14. Han, S. W., D. G. Evans, F. A. el-Zaatari, M. F. Go, and D. Y. Graham. 1996. The interaction of pH, bile, and Helicobacter pylori may explain duodenal ulcer. Am. J. Gastroenterol. 91:1135-1137.
15. Hanninen, M. L. 1991. Sensitivity of Helicobacter pylori to different bile salts. Eur. J. Clin. Microbiol. Infect. Dis. 10:515-518.
16. Haque, M., Y. Hirai, K. Yokota, N. Mori, I. Jahan, H. Ito, H. Hotta, I. Yano, Y. Kanemasa, and K. Oguma. 1996. Lipid profile of Helicobacter spp.: presence of cholesteryl glucoside as a characteristic feature. J. Bacteriol. 178: 2065-2070.
17. Haque, M., Y. Hirai, K. Yokota, and K. Oguma. 1995. Lipid profiles of Helicobacter pylori and Helicobacter mustelae grown in serum-supplemented and serum-free media. Acta Medica Okayama 49:205-211.
18. Haque, M., Y. Hirai, K. Yokota, and K. Oguma. 1995. Steryl glycosides: a characteristic feature of the Helicobacter spp.? J. Bacteriol. 177:5334-5337.
19. Hildebrandt, E., and D. J. McGee. 2009. Helicobacter pylori lipopolysaccha-ride modification, Lewis antigen expression, and gastric colonization are cholesterol-dependent. BMC Microbiol. 9:258.
20. Hirai, Y., M. Haque, T. Yoshida, K. Yokota, T. Yasuda, and K. Oguma. 1995. Unique cholesteryl glucosides in Helicobacter pylori: composition and structural analysis. J. Bacteriol. 177:5327-5333.
21. Inamoto, Y., S. Hamanaka, Y. Hamanaka, T. Nagate, I. Kondo, T. Takemoto, and K. Okita. 1995. Lipid composition and fatty acid analysis of Helicobacter pylori. J. Gastroenterol. 30:315-318.
22. Itoh, M., K. Wada, S. Tan, Y. Kitano, J. Kai, and I. Makino. 1999. Antibacterial action of bile acids against Helicobacter pylori and changes in its ultrastructural morphology: effect of unconjugated dihydroxy bile acid. J. Gastroenterol. 34:571-576.
23. Kawakubo, M., Y. Ito, Y. Okimura, M. Kobayashi, K. Sakura, S. Kasama, M. N. Fukuda, M. Fukuda, T. Katsuyama, and J. Nakayama. 2004. Natural antibiotic function of a human gastric mucin against Helicobacter pylori infection. Science 305:1003-1006.
24. Koronakis, V., J. Eswaran, and C. Hughes. 2004. Structure and function of TolC: the bacterial exit duct for proteins and drugs. Annu. Rev. Biochem. 73:467-489.
25. Kutschke, A., and B. L. de Jonge. 2005. Compound efflux in Helicobacter pylori. Antimicrob. Agents Chemother. 49:3009-3010.
26. Langford, M. L., J. Zabaleta, A. C. Ochoa, T. L. Testerman, and D. J. McGee. 2006. In vitro and in vivo complementation of the Helicobacter pylori arginase mutant using an intergenic chromosomal site. Helicobacter 11:477-493.
27. Lee, H., P. Wang, H. Hoshino, Y. Ito, M. Kobayashi, J. Nakayama, P. H. Seeberger, and M. Fukuda. 2008. a1,4GlcNAc-capped mucin-type O-glycan inhibits cholesterol alpha-glucosyltransferase from Helicobacter pylori and suppresses H. pylori growth. Glycobiology 18:549-558.
28. Leszczynska, K., A. Namiot, D. E. Fein, Q. Wen, Z. Namiot, P. B. Savage, S. Diamond, P. A. Janmey, and R. Bucki. 2009. Bactericidal activities of the cationic steroid CSA-13 and the cathelicidin peptide LL-37 against Helicobacter pylori in simulated gastric juice. BMC Microbiol. 9:187.
29. Li, C, M. R. Lewis, A. B. Gilbert, M. D. Noel, D. H. Scoville, G. W. Allman, and P. B. Savage. 1999. Antimicrobial activities of amine-and guanidine-functionalized cholic acid derivatives. Antimicrob. Agents Chemother. 43: 1347-1349.
30. Lin, J., C. Cagliero, B. Guo, Y. W. Barton, M. C. Maurel, S. Payot, and Q. Zhang. 2005. Bile salts modulate expression of the CmeABC multidrug efflux pump in Campylobacter jejuni. J. Bacteriol. 187:7417-7424. (Pubitemid 41507798)
31. Liu, Z. Q., P. Y. Zheng, and P. C. Yang. 2008. Efflux pump gene hefA of Helicobacter pylori plays an important role in multidrug resistance. World J. Gastroenterol. 14:5217-5222.
32. Ma, D., D. N. Cook, M. Alberti, N. G. Pon, H. Nikaido, and J. E. Hearst. 1995. Genes acrA and acrB encode a stress-induced efflux system of Escherichia coli. Mol. Microbiol. 16:45-55.
33. Mathai, E., A. Arora, M. Cafferkey, C. T. Keane, and C. O'Morain. 1991. The effect of bile acids on the growth and adherence of Helicobacter pylori. Aliment. Pharmacol. Ther. 5:653-658.
34. Nakayama, F. 1967. Quantitative microanalysis of bile. J. Lab. Clin. Med. 69:594-609.
35. Okoli, A. S., T. Wadstrom, and G. L. Mendz. 2007. Minireview: bioinformatic study of bile responses in Campylobacterales. FEMS Immunol. Med. Microbiol. 49:101-123.
36. Pos, K. M. 2009. Drug transport mechanism of the AcrB efflux pump. Biochim. Biophys. Acta 1794:782-793.
37. Saha, S., P. B. Savage, and M. Bal. 2008. Enhancement of the efficacy of erythromycin in multiple antibiotic-resistant gram-negative bacterial pathogens. J. Appl. Microbiol. 105:822-828.
38. Schindlbeck, N. E., C. Heinrich, F. Stellaard, G. Paumgartner, and S. A. Muller-Lissner. 1987. Healthy controls have as much bile reflux as gastric ulcer patients. Gut 28:1577-1583.
39. Stahler, F. N., S. Odenbreit, R. Haas, J. Wilrich, A. H. Van Vliet, J. G. Kusters, M. Kist, and S. Bereswill. 2006. The novel Helicobacter pylori CznABC metal efflux pump is required for cadmium, zinc, and nickel resistance, urease modulation, and gastric colonization. Infect. Immun. 74:3845-3852.
40. Testerman, T. L., P. B. Conn, H. L. Mobley, and D. J. McGee. 2006. Nutritional requirements and antibiotic resistance patterns of Helicobacter species in chemically defined media. J. Clin. Microbiol. 44:1650-1658.
41. Testerman, T. L., D. J. McGee, and H. L. Mobley. 2001. Helicobacter pylori growth and urease detection in the chemically defined medium Ham's F-12 nutrient mixture. J. Clin. Microbiol. 39:3842-3850.
42. Tomb, J. F., O. White, A. R. Kerlavage, R. A. Clayton, G. G. Sutton, R. D. Fleischmann, K. A. Ketchum, H. P. Klenk, S. Gill, B. A. Dougherty, K. Nelson, J. Quackenbush, L. Zhou, E. F. Kirkness, S. Peterson, B. Loftus, D. Richardson, R. Dodson, H. G. Khalak, A. Glodek, K. McKenney, L. M. Fitzegerald, N. Lee, M. D. Adams, E. K. Hickey, D. E. Berg, J. D. Gocayne, T. R. Utterback, J. D. Peterson, J. M. Kelley, M. D. Cotton, J. M. Weidman, C. Fujii, C. Bowman, L. Watthey, E. Wallin, W. S. Hayes, M. Borodovsky, P. D. Karp, H. O. Smith, C. M. Fraser, and J. C. Venter. 1997. The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature 388: 539-547.
43. van Amsterdam, K., A. Bart, and A. van der Ende. 2005. A Helicobacter pylori TolC efflux pump confers resistance to metronidazole. Antimicrob. Agents Chemother. 49:1477-1482.
44. Waidner, B., K. Melchers, I. Ivanov, H. Loferer, K. W. Bensch, M. Kist, and S. Bereswill. 2002. Identification by RNA profiling and mutational analysis of the novel copper resistance determinants CrdA (HP1326), CrdB (HP1327), and CzcB (HP1328) in Helicobacter pylori. J. Bacteriol. 184:6700-6708.
45. Waidner, B., K. Melchers, F. N. Stahler, M. Kist, and S. Bereswill. 2005. The Helicobacter pylori CrdRS two-component regulation system (HP1364/HP1365) is required for copper-mediated induction of the copper resistance determinant CrdA. J. Bacteriol. 187:4683-4688.
46. Wunder, C., Y. Churin, F. Winau, D. Warnecke, M. Vieth, B. Lindner, U. Zahringer, H. J. Mollenkopf, E. Heinz, and T. F. Meyer. 2006. Cholesterol glucosylation promotes immune evasion by Helicobacter pylori. Nat. Med. 12:1030-1038.